At a glance
- Originator Aventis
- Class
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cognition disorders; Epilepsy; Neurological disorders
Most Recent Events
- 29 Jan 1997 Discontinued-Preclinical for Epilepsy in USA (unspecified route)
- 29 Jan 1997 Discontinued-Preclinical for Neurological disorders in USA (unspecified route)
- 09 Dec 1996 Preclinical development for Neurological disorders in USA (unspecified route)